| Citation: |
REN Weiwei, WANG Chao, MENG Junhua, XU Suhong. Establishment and validation of an individualized risk prediction nomogram model for gestational diabetes mellitus in pregnant women with hypothyroidism[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 93-97. DOI: 10.7619/jcmp.20234265
|
To establish and validate an individualized risk prediction nomogram model for the occurrence of gestational diabetes mellitus in pregnant women with hypothyroidism.
A total of 160 pregnant women with hypothyroidism were selected as the study subjects, including 85 patients with gestational diabetes mellitus (observation group) and 75 patients with normal blood glucose levels (control group). The age, gravidity, parity as well as pre-pregnancy body mass index, thyroid peroxidase antibody (TPOAb), homeostatic model assessment of insulin resistance (HOMA-IR), homeostatic model assessment of beta-cell function (HOMA-β), free thyroxine (FT4), free triiodothyronine (FT3) and thyroid stimulating hormone (TSH) were compared between the two groups. Multivariable analysis was used to analyze the risk factors for gestational diabetes mellitusin pregnant women with hypothyroidism. The nomogram model was used to predict the risk of gestational diabetes mellitus in pregnant women with hypothyroidism. The receiver operating characteristic (ROC) curve was used to evaluate the predictive value of the nomogram model for gestational diabetes mellitus in pregnant women with hypothyroidism.
The age, gravidity, parity as well as pre-pregnancy body mass index, TPOAb, HOMA-IR and HOMA-β were higher in the observation group than in the control group, while pre-pregnancy FT4, FT3 and TSH were lower (P < 0.05). Multivariable analysis showed that older age, gravidity, parity as well as pre-pregnancy body mass index, TPOAb, HOMA-IR and HOMA-β, and lower pre-pregnancy FT4, FT3 and TSH were risk factors for gestational diabetes mellitusin pregnant women with hypothyroidism. The nomogram model prediction showed that older age (28 to 31 years), gravidity (more than 2 times), parity (more than 1 time) as well as pre-pregnancy body mass index (above 24.00 kg/m2), TPOAb (> 421.33 IU/mL), HOMA-IR (> 2.21) and HOMA-β (> 115.66), and lower pre-pregnancy FT4 (< 0.33 ng/dL), FT3 (< 1.65 pg/mL) and TSH (< 0.26 mIU/mL) were risk factors for gestational diabetes mellitus in pregnant women with hypothyroidism. ROC curve analysis showed that the area under the curve of the nomogram model for predicting gestational diabetes mellitus in pregnant women with hypothyroidism was 0.785, indicating good predictive performance.
The risk prediction nomogram model has high value in individualized prediction of gestational diabetes mellitus in pregnant women with hypothyroidism.
| [1] |
王玲玲, 郭志国, 陶晓明, 等. 亚甲基四氢叶酸还原酶基因多态性及甲状腺功能与妊娠期糖尿病的相关性[J]. 中国实验诊断学, 2021, 25(6): 825-829. doi: 10.3969/j.issn.1007-4287.2021.06.009
|
| [2] |
BOZDAG H, AKDENIZ E. Does severe vitamin D deficiency impact obstetric outcomes in pregnant women with thyroid autoimmunity[J]. J Matern Fetal Neonatal Med, 2020, 33(8): 1359-1369.
|
| [3] |
BIRRU R L, LIANG H W, FAROOQ F, et al. A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus[J]. Environ Health, 2021, 20(1): 63.
|
| [4] |
KENT N L, YOUNG S L, AKISON L K, et al. Is the link between elevated TSH and gestational diabetes mellitus dependant on diagnostic criteria and thyroid antibody status: a systematic review and meta-analysis[J]. Endocrine, 2021, 74(1): 38-49.
|
| [5] |
王丽, 侯艳萍, 贾广珠. 妊娠期糖尿病孕妇血清甲状腺激素水平与剖宫产术后感染风险的关系[J]. 中国妇幼保健, 2020, 35(23): 4471-4474.
|
| [6] |
赵玲玲. 甲状腺功能减退对妊娠期糖尿病孕妇糖代谢及胰岛素敏感性的影响[J]. 中国妇幼保健, 2020, 35(4): 634-636.
|
| [7] |
肖进, 李国敏, 田倩. 妊娠期糖尿病孕妇血清PLGF、TPOAb、HbA1c水平与母婴结局[J]. 中国计划生育学杂志, 2021, 29(8): 1627-1631.
|
| [8] |
袁清操, 仝俊瑶, 邹密, 等. 妊娠期低甲状腺素血症对妊娠期并发症及不良结局的影响[J]. 实用妇产科杂志, 2021, 37(4): 302-306.
|
| [9] |
金辉, 陈方圆, 吴跃跃, 等. 妊娠早中期持续孤立性低甲状腺素血症对妊娠期并发症及不良结局的影响[J]. 中华内分泌代谢杂志, 2022, 38(1): 19-23. doi: 10.3760/cma.j.cn311282-20210710-00445
|
| [10] |
李艳艳, 赵旭敏. 妊娠期亚临床甲减TPOAb阴性孕妇不同时间左甲状腺素钠片治疗对妊娠结局及幼儿神经功能影响[J]. 中国计划生育学杂志, 2021, 29(7): 1383-1387.
|
| [11] |
郑皓宇, 胥东, 施蒙娜, 等. 妊娠期甲状腺功能减退症孕妇不同时期治疗效果及妊娠结局[J]. 中国计划生育学杂志, 2021, 29(1): 61-64.
|
| [12] |
李萍, 崔金晖, 李玲, 等. 甲状腺功能减退妇女早孕期促甲状腺素达标与否与妊娠期糖尿病发生的关系[J]. 中华糖尿病杂志, 2021, 13(11): 1075-1080. doi: 10.3760/cma.j.cn115791-20210418-00217
|
| [13] |
SHAHID M M, THOUHIDUR RAHMAN K M T, GOMES R R, et al. Association of gestational diabetes mellitus and thyroid status during pregnancy: a cross-sectional study in a tertiary health care center of Bangladesh[J]. Gynecol Endocrinol, 2021, 37(4): 312-314.
|
| [14] |
王海燕, 穆庆芬, 马生秀. 妊娠早期甲状腺功能减退与妊娠期糖尿病及糖代谢指标的关系[J]. 中国妇产科临床杂志, 2020, 21(1): 43-45.
|
| [15] |
DUCARME G, DESROYS DU ROURE V, LE THUAUT A, et al. Subclinical hypothyroidism is not associated with neonatal morbidity in women with gestational diabetes mellitus: a case-control study[J]. Arch Gynecol Obstet, 2021, 303(5): 1153-1159.
|
| [16] |
林海玲, 王利果. 甲状腺功能减退对妊娠期糖尿病患者糖脂代谢、心功能及妊娠结局的影响[J]. 中国妇幼保健, 2020, 35(8): 1386-1389.
|
| [17] |
RADOSA J C, RADOSA M P, ZIMMERMANN J S M, et al. Incidence of and risk factors for vaginal cuff dehiscence following total laparoscopic hysterectomy: a monocentric hospital analysis[J]. Arch Gynecol Obstet, 2021, 304(2): 447-454.
|
| [18] |
林晶, 陈宇清, 陈蕾. 妊娠期糖尿病妇女甲状腺功能与胰岛素抵抗及胰岛β细胞功能的相关性[J]. 现代妇产科进展, 2021, 30(8): 593-596.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: